Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data

Josh Feng1, Matthew J Higgins2,3,4, Elena Patel1

  • 1The University of Utah, Salt Lake City, Utah, USA.

Health Economics
|November 15, 2025
PubMed

Insights

Asthma medication adherence significantly decreased during the COVID-19 pandemic, especially in young children. Parental attention influenced these adherence trends, highlighting a need for improved pediatric asthma management strategies.

Area of Science:

  • Public Health
  • Pediatrics
  • Health Services Research

Background:

  • The COVID-19 pandemic presented unprecedented challenges to healthcare access and patient behaviors.
  • Asthma medication adherence is crucial for managing the condition and preventing exacerbations, particularly in pediatric populations.
  • Understanding pandemic-related impacts on adherence is vital for maintaining chronic disease management.

Purpose of the Study:

  • To analyze trends in asthma control medication adherence in the U.S. during the COVID-19 pandemic.
  • To investigate age-specific differences in adherence changes among children and adults.
  • To explore factors, such as parental attention, influencing adherence declines.

Main Methods:

  • Utilized comprehensive U.S. drug claims data to track medication adherence.
  • Analyzed adherence rates across different age groups (young children, older children, adults).
  • Examined heterogeneity in adherence based on pre-pandemic mail order usage and parental script data.

Main Results:

  • Overall adherence to asthma control medication declined during the pandemic.
  • Young children experienced a substantial 40% decrease in adherence by late 2020.
  • Older children showed less negative responses, while adults exhibited positive adherence trends.
  • Pre-pandemic mail order usage and number of parental scripts correlated with adherence changes, suggesting a role for parental attention.

Conclusions:

  • The COVID-19 pandemic negatively impacted asthma medication adherence, with young children being the most affected.
  • Parental factors appear to play a significant role in pediatric adherence during public health crises.
  • Findings underscore the need for targeted interventions to support pediatric asthma management and adherence.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
237
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182